AMRX EPS Estimates
Amneal Pharmaceuticals, Inc.
$19.46
+$0.56(+2.96%)
65
Overall
40
Value
91
Tech
65
Quality
Market Cap
$6.58B
Volume
1.30M
52W Range
$9.56 - $21.18
Target Price
$22.00
AMRX EPS estimates: the consensus estimate for Amneal Pharmaceuticals, Inc.'s current fiscal year is $0.95 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AMRX EPS Estimates
- EPS estimate, current quarter
- $0.21
- EPS estimate, next quarter
- $0.22
- EPS estimate, current year
- $0.95
- EPS estimate, next year
- $1.08
- EPS growth, 3-year
- +31.37%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.23 |
| 2024 | $-0.38 |
| 2023 | $-0.48 |
| 2022 | $-0.86 |
| 2021 | $0.07 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMRX | $19.46 | +3.0% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amneal Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW